Related Experiment Video
Updated: Jul 10, 2026
09:52
Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)
Published on: April 19, 2013
Genetic polymorphisms in susceptibility to Type 1 Diabetes
Behrooz Z Alizadeh1, Bobby P C Koeleman
1Complex Genetics Section, Department of Medical Genetics, University Medical Center Utrecht, The Netherlands.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|October 30, 2007
Summary
Type 1 Diabetes (T1D) is a complex childhood disease influenced by genetics and environment. This review summarizes key genetic factors and discusses ongoing research into T1D
Area of Science:
- Immunology
- Genetics
- Endocrinology
Background:
- Type 1 Diabetes (T1D) is a prevalent childhood autoimmune disease with lifelong treatment needs.
- T1D pathogenesis involves complex interactions between genetic predisposition and environmental triggers.
- Significant mortality associated with T1D stems from long-term complications.
Purpose of the Study:
- To review the current understanding of genetic factors contributing to Type 1 Diabetes.
- To discuss major genetic polymorphisms and their roles in T1D etiology.
- To provide perspective on identified and potential genetic risk factors for T1D.
Main Methods:
- Comprehensive literature review of genetic studies on Type 1 Diabetes.
- Analysis of identified genetic variants and associated loci.
- Synthesis of data on major genetic polymorphisms in T1D.
Main Results:
- Decades of research have identified numerous genetic variants and loci linked to T1D.
- Understanding of T1D's genetic architecture has significantly advanced.
- Key genetic polymorphisms involved in T1D have been cataloged.
Conclusions:
- Genetic factors play a crucial role in the development of Type 1 Diabetes.
- Continued genetic research is vital for developing better diagnostic and therapeutic tools.
- Further investigation is needed to identify all contributing genetic risk factors for T1D.
Related Concept Videos
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...